Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastine vs Granulokine in Breast Cancer Patients Treated with Chemotherapy
NCT05790096Phase 3Unknown
- Sponsor
- Blau Farmacêutica
- Start
- May 2023
- Primary completion
- Jun 2024
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of filgrastim in neutropenia, sponsored by Blau Farmacêutica. Status: unknown.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT05790096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05790096.